AllAnalyst Report
logoMorningstarMay 06, 2021

Charles River Laboratories International, Inc.: Charles River Reports Strong Q1 Results and Momentum for a Healthy 2021; Raising FVE to $170

Symbols
CRL
Sector(s)
Healthcare
Rating
Current Price
$229.03
Fair Value
Economic Moat
Stewardship
Summary

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company’s research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The

Upgrade to begin using premium research reports and get so much more.

Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
Upgrade